Metagenomi Therapeutics (MGX) FCF Margin (2023 - 2026)
Metagenomi Therapeutics' FCF Margin was -1698.72% in Q1 2026, down 1138.26 percentage points from -560.46% a year earlier and down 1094.50 percentage points from the prior quarter.
Powered by 
Analysis
Metagenomi Therapeutics (MGX) FCF Margin (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Metagenomi Therapeutics' FCF Margin was -391.99% through Mar 31, 2026, down 161.01 percentage points year-over-year; for FY2025, it was -354.88%, down 140.36 percentage points from FY2024.
- In earlier years, FCF Margin was -214.53% in FY2024 (+11.64 pp) and -226.17% in FY2023.
- The Q1 2026 figure marks the lowest quarterly FCF Margin in data going back to Q1 2023.
- Compared with a year earlier, FCF Margin has declined for seven straight quarters, with an average year-over-year change of -234.55 percentage points over the last eight quarters.
- The best year-over-year quarter for FCF Margin over five years was Q2 2024 (a gain of 123.12 percentage points); the worst was Q1 2026 (a drop of 1138.26 percentage points).
- Per Business Quant data, MGX's FCF Margin in the three quarters before Q1 2026 was -604.22% (Q4 2025), -246.30% (Q3 2025) and -251.12% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Metagenomi Therapeutics | 42.69 Mn | 42.69 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1,698.72% |
| Dec 31, 2025 | -604.22% |
| Sep 30, 2025 | -246.30% |
| Jun 30, 2025 | -251.12% |
| Mar 31, 2025 | -560.46% |
| Dec 31, 2024 | -276.78% |
| Sep 30, 2024 | -241.78% |
| Jun 30, 2024 | -134.82% |
| Mar 31, 2024 | -275.70% |
| Dec 31, 2023 | -180.09% |
| Sep 30, 2023 | -210.22% |
| Jun 30, 2023 | -257.93% |
| Mar 31, 2023 | -273.34% |
API Access
Metagenomi Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=MGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "MGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=MGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();